Physician profile
James A Hicks
NPI 1649288226
$5,694.32
in general payments reported to CMS, 2019-2025
46 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2020: $168 · 2021: $334 · 2022: $988 · 2023: $838 · 2024: $1,158 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $847.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $561.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $533.94 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $433.44 | 2019-2025 | |
| Lilly USA, LLC | $383.68 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $309.79 | 2020-2021 | |
| Dexcom, INC. | $247.65 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.05 | 2019-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $203.68 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $178.55 | 2019-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $161.97 | 2019-2024 | |
| Glaxosmithkline, LLC. | $152.08 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.25 | 2019-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $122.16 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $109.43 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $89.59 | 2021-2024 | Trintellix |
| Amarin Pharma, INC. | $83.65 | 2019-2022 | |
| Exact Sciences Corporation | $81.02 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $76.85 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.85 | 2022 | |
| Dynavax Technologies Corporation | $60.30 | 2024-2025 | Heplisav-B |
| Stryker Corporation | $51.39 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alexion Pharmaceuticals, INC. | $48.12 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $40.39 | 2025 | Rosa |
| Sumitomo Pharma America, INC. | $38.89 | 2024 | Gemtesa |
| Allergan, INC. | $34.20 | 2019-2020 | |
| Shire North American Group INC | $33.81 | 2019 | |
| Daiichi Sankyo INC. | $33.00 | 2023-2025 | Injectafer |
| Boston Scientific Corporation | $32.88 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Inari Medical, INC. | $30.51 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corcept Therapeutics | $28.48 | 2024-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $26.56 | 2019-2025 | |
| Inspire Medical Systems, INC. | $23.51 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $22.24 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biogen, INC. | $21.96 | 2024 | Skyclarys |
| Jazz Pharmaceuticals INC. | $20.12 | 2020 | |
| Supernus Pharmaceuticals, INC. | $16.01 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.75 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $12.96 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.89 | 2023 | |
| Mylan Specialty L.P. | $12.24 | 2019 | |
| Currax Pharmaceuticals LLC | $11.74 | 2019 | |
| Therapeuticsmd, INC. | $11.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.96 | 2019 | |
| Antares Pharma, INC. | $10.80 | 2019 | |
| Organon LLC | $10.00 | 2024-2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.